Ann: Half Year Report and Financial Statements, page-15

First 15 Last

Share
Profile

Follow
lrp

255 Posts.

6

21/03/18

11:13

Post #: 31911622
Share

Originally posted by stormer ↑

''Whilst, and this definitely is not my opinion btw, we lack the charisma and leaders to excite people and get investors on board,''

BT..This isn't a question of opinion...it's fact..the share price and share register are proof of this. It's incontrovertible

It's interesting that you use the example on Innate Immuno. Yes, you are right that the trial failed and the stock collapsed. What you fail to mention is that for every person who held to the time of the trial result, another 100 others traded in and out of the stock all the way up to $1.80 and many would have made huge profits along the way

The point is that their leadership did have the charisma and were able to generate sufficient interest in the science ts push the stock up to a market cap of a few hundred million. Let's not forget that probably 1% of holders held from the outset to the trial result, because about 99% of the trials fail

So it's easy to choose a point in time to support your conclusion. Fact is DXB have been an appalling failure at generating interest in the company and this has meant that none of us have had the choice to exit with a decent profit on the way to final trial results....this is an opportunity that investors in pretty much every other biotech I have seen have had the chance to do

We are now prisoners to the trial results, and , as we know in biotech, nothing is without substantial risk

So I remain hugely frustrated and disappointed with DXB's Board and management and i still believe they lag other biotech stocks massively in this regard

Expand

Yep, some companies seem to work on a pump and dump approach. I'm not interested in investing in them as getting the timing right is way too hard and for every investor who gains, just as many lose.

DXB Price at posting: 13.0¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

First 15 Last

(20min delay)
Last 35.0¢		Change -0.025(6.67%)		Mkt cap ! $25.68M

Open	High	Low	Value	Volume
37.0¢	37.0¢	35.0¢	$387.8K	1.079M

Buyers (Bids)

No.	Vol.	Price($)
11	394907	35.0¢

Sellers (Offers)

Price($)	Vol.	No.
36.5¢	15948	1

View Market Depth

No.	Vol.	Price($)
1	75000	0.086
4	139056	0.085
2	158037	0.084
1	50000	0.083
2	29695	0.082

Price($)	Vol.	No.
0.087	1995	1
0.090	50000	1
0.091	76873	1
0.092	99798	1
0.093	50000	1

Last trade - 16.10pm 12/12/2024 (20 minute delay)

DXB (ASX) Chart

Ann: Half Year Report and Financial Statements, page-15

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News